What is Preclinical Tomography System Market?
Tomography is a radiologic technique for obtaining clear x-ray images of deep internal structures by focusing on a specific plane within the body. Preclinical tomography system helps to diagnose the disease or disease condition prior to the appearance of symptoms for the proper treatment. It is also used for research purposes and can be used for drug development. The companies are collaborating with biotechnology and pharmaceutical companies driving the preclinical tomography system market. Preclinical tomography system market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024.
The market study is being classified by Type (Ultrasound, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Positron Emission Tomography Scanners (PET) and Single Photon Emission Tomography Scanners (SPECT)), by Application (Biopharmaceuticals, Research Institute, Hospitals and Clinics and Others) and major geographies with country level break-up.
Bruker Corporation (United States), PerkinElmer, Inc. (United States), FUJIFILM Holdings Corporation (Japan), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), LI-COR Biosciences (United States), MR Solutions (United Kingdom), Aspect Imaging (Israel), Miltenyi Biotech GmbH (Germany) and TriFoil Imaging (United States) are some of the key players profiled in the study.
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Preclinical Tomography System market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Preclinical Tomography System market by Type, Application and Region.
On the basis of geography, the market of Preclinical Tomography System has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Increasing Research and Development Activities
- Demand from Pharmaceutical Companies
- Increasing Adoption of Preclinical Tomography Systems
Market Trend
- Companies Launching the Products with Advanced Features
Restraints
- High Cost of the Preclinical Tomography Systems
Opportunities
- Government Initiatives for Research and Development Activities
- Increasing Applications in Various Industries
Challenges
- Lack of Awareness among the Emerging Countries
- Government Rules and Regulations for Preclinical Research
Market Leaders and some development strategies
On 22nd November 2016, Brucker Corporation completed the acquisition of the preclinical PET imaging business of Oncovision, a leading provider of innovative medical imaging devices.
On 14th September 2018, Brucker Corporation announced the introduction of the new preclinical PET/CT Si78 scanner for whole-body molecular imaging. It involves a combination of Brucker’s novel PET and outstanding micro-CT technologies in a single scanner operated by the multi-modality imaging software platform ParaVision 360.
Key Target Audience
Preclinical Tomography System Manufacturers, Raw Material Suppliers/ Buyers, Distributors, Research Institutes, Government Body & Associations and End-user